Breast Cancer
"CYP17 Genotype and Breast Cancer Risk."
Published in Cancer Weekly, December 7th, 1998
According to the authors' abstract of an article published in Cancer Epidemiology Biomarkers & Prevention, "The MspAI polymorphism in the 5' untranslated region of CYP17 has been evaluated as a breast cancer risk factor in a hospital-based, case-control study in New York City. The study population consisted of 363 women [123 breast cancer patients and 240 patient controls (123 benign breast disease without atypical hyperplasia, 117 women without breast disease)]. There were 224 Caucasians (76 cases, 148 controls), 55 African-Americans (20 cases, 35 controls), and 84 Hispanics (27 cases, 57 controls), 142 pre-menopausal women, and 221 post-menopausal women. Consistent with a previous...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-12-07)
More Articles from Cancer Weekly
- Suicide Gene Therapy
Tissue-Specific Promoter Targets Cervical Cancer - Cancer Gene Therapy
Antisense Control of Cyclin D1 Reduces Proliferation - Cancer Genetics
Process Identifies a Novel Oncogene - Cancer Immunotherapy
Chemo/Immunotherapy Tolerable in Renal Cancer Patients - Cancer Immunotherapy
Defective Maturation of Hemopoietic Progenitors Creates Complications - Cancer Immunotherapy
Immunological Parameters of TNF(alpha) Immunotherapy Identified - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
